TY - JOUR
T1 - Metformin-induced thyrotropin suppression is not associated with cardiac effects
AU - Cappelli, Carlo
AU - Rotondi, Mario
AU - Pirola, Ilenia
AU - Agosti, Barbara
AU - Formenti, Ana Maria
AU - De Cata, Pasquale
AU - Salvetti, Massimo
AU - Chiovato, Luca
AU - Castellano, Maurizio
PY - 2014
Y1 - 2014
N2 - Objective: Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine. Design: Heart rate, P wave duration, P wave dispersion, QTmax, QTmin and QT-dispersion were assessed in 23 patients with diabetes treated with metformin before and after 6 months of TS H-suppression and in 31 control patients with SHT. Results: No significant changes in electrocardiographic parameters were observed from baseline to the TSH-suppression measurement. A significant difference in P wave duration (102.9±7.4 vs. 92.1±5.8 ms, p
AB - Objective: Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine. Design: Heart rate, P wave duration, P wave dispersion, QTmax, QTmin and QT-dispersion were assessed in 23 patients with diabetes treated with metformin before and after 6 months of TS H-suppression and in 31 control patients with SHT. Results: No significant changes in electrocardiographic parameters were observed from baseline to the TSH-suppression measurement. A significant difference in P wave duration (102.9±7.4 vs. 92.1±5.8 ms, p
KW - Atrial fibrillation
KW - Metformin
KW - Sub-clinical hyperthyroidism
UR - http://www.scopus.com/inward/record.url?scp=84899646067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899646067&partnerID=8YFLogxK
M3 - Article
C2 - 24776625
AN - SCOPUS:84899646067
VL - 13
SP - 252
EP - 258
JO - Hormones
JF - Hormones
SN - 1109-3099
IS - 2
ER -